A shift in genetic classification and new data on metabolic triggers are transforming Alzheimer’s from a vague aging risk into a predictable, systemic disease driven by DNA and ...
A 24-year-old man from Norfolk who developed aggressive frontotemporal dementia donated his brain to Addenbrooke’s Hospital to help researchers study early-onset disease and its...
A Northwestern small molecule halts early toxic protein damage in mice, joining recent studies that point to lithium balance, gene editing and new biomarkers as routes to preven...
New EEG-based AI models are showing promise for earlier, cheaper detection of Alzheimer’s and frontotemporal dementia; recent studies highlight explainable, privacy-preserving c...
We use cookies
We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept", you consent to our use of cookies.